Olfax, LLC

Pharmaceutical company · Asheville, North Carolina, United States

Olfax, LLC is a pharmaceutical company headquartered in Asheville, North Carolina, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $336,946 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $110,000 sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Olfax at a glance

Typepharmaceutical company
HeadquartersAsheville, North Carolina, United States
Employees (self-reported, 2022)3
SEC CIK2026135

What does Olfax do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $336,946 in total (2022). NIH funding came from the National Institute of Neurological Disorders and Stroke.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $110,000 sold (2024).

Frequently asked questions about Olfax

Where is Olfax headquartered?

Olfax, LLC is headquartered in Asheville, North Carolina, United States.

What does Olfax do?

Olfax, LLC is a pharmaceutical company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences